FOLD — Amicus Therapeutics Income Statement
0.000.00%
Last trade - 00:00- $3.13bn
- $3.24bn
- $399.36m
- 49
- 14
- 48
- 30
Annual income statement for Amicus Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 182 | 261 | 306 | 329 | 399 |
| Cost of Revenue | |||||
| Gross Profit | 160 | 230 | 271 | 291 | 362 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 527 | 515 | 512 | 541 | 491 |
| Operating Profit | -345 | -254 | -207 | -212 | -91.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -356 | -274 | -242 | -242 | -150 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -356 | -277 | -250 | -237 | -152 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -356 | -277 | -250 | -237 | -152 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -356 | -277 | -250 | -237 | -152 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.37 | -1.05 | -0.922 | -0.804 | -0.48 |